National brain tumour research funding needs to increase to £35 million a year
New technology will accelerate research and discovery
Scientists at the University of Plymouth are set to take the next steps in major medical research after winning prestigious funding.
Announced today, the funding from the Wolfson Foundation, an independent, grant-making charity with a focus on research and education, means that teams at the university will benefit from a new state-of-the-art mass spectrometer.
It is hoped that the cutting-edge equipment will enable scientists, including the research team at our Plymouth Centre of Excellence, to accelerate the next step in developing research insights and to bring new treatments forwards.
The machine is used in proteomics – the in-depth study of proteins – and will help to facilitate a wide range of research, including into brain tumours. It will enable researchers to analyse samples up to 10 times faster than their current technology permits, meaning accelerated results and potentially faster rollout of treatments.
The versatility of the new model of mass spectrometer will also result in a wider range of research applications, increasing the potential for local, national and international collaboration.
Professor Oliver Hanemann, Principal Investigator at our Plymouth Research Centre, said: “Access to this modern mass spectrometer builds on the equipment we are able to employ in our brain tumour work. It will deliver speed to our protein analysis and this will translate into faster research insights and ultimately new treatments to patients being available sooner.”
We welcome this news and the benefits it will bring to the vital research into low-grade tumours being undertaken by Professor Hanemann and his team.
If you found this story interesting or helpful, sign up to our weekly e-news and keep up to date with all the latest from Brain Tumour Research.